CT and PET-CT response assessment at 6 months (end of combination therapy)
| Method of assessment . | N evaluable patients . | CR, % . | 95% CI (Clopper Pearson) . | ORR, % . | 95% CI (Clopper Pearson) . |
|---|---|---|---|---|---|
| CT | 24 | 25.0 | (9.8; 46.7%) | 87.5 | (67.6; 97.3%) |
| PET/CT | 19 | 68.4 | (43.4; 87.4%) | 84.2 | (60.4; 96.6%) |
| Method of assessment . | N evaluable patients . | CR, % . | 95% CI (Clopper Pearson) . | ORR, % . | 95% CI (Clopper Pearson) . |
|---|---|---|---|---|---|
| CT | 24 | 25.0 | (9.8; 46.7%) | 87.5 | (67.6; 97.3%) |
| PET/CT | 19 | 68.4 | (43.4; 87.4%) | 84.2 | (60.4; 96.6%) |